Nanodiscs are artificial scaffolds that mimic the phospholipid bilayer surrounding every living cell. They allow the reconstitution and stabilization of membrane proteins in a native conformation, thus enabling functional studies of these important drug targets. Nanodiscs might also pave the way for the application of membrane proteins in future diagnostic assays.
What are Nanodiscs?
In the nanodisc, the synthetic phospholipid bilayer of phospholipid is held together by a ring formed by two molecules of an amphipathic helical membrane scaffold protein (MSP) derived from apolipoprotein A-I of human, rat, or mouse origin (Fig.1). Since the lipophilic components of the membrane proteins are masked inside the lipid bilayer, the membrane proteins can be purified via standard chromatography methods without the addition of detergent. For purification, the membrane protein itself can be tagged, or purification can be performed utilizing the His-tag fused to the MSP. Membrane protein-nanodisc complexes show an increased stability compared to detergent-solubilized membrane proteins.
Why use Nanodiscs?
Nanodiscs are not the only option to study correctly folded, active membrane proteins. However, they have a number of advantages compared to commonly used methods:
The prevalently used nanodisc scaffold protein variant is MSP1D1. The protein comprises 10 a-helices similar to Apo A-I but with a modified N-terminus and increased stability of the assembled disc compared to the original MSP1. MSP1D1-deltaH5 corresponds to MSP1D1 except for a deletion of helix 5, thus resulting in a nanodisc complex with smaller diameter more suitable e.g. for NMR studies. MSP1E3D1 on the other hand has been extended by a duplication of three helices whereas MSP2N2 corresponds to a full length MSP1D1 fused via a short linker to a truncated MSP1D2 protein. These extended forms render larger diameter nanodiscs possible that are suitable for the incorporation of larger protein complexes.
Besides structural MSP variants, recombinant MSP1D1 and MSP1E3D1 can be of human, mouse, or rat origin. These species specific variants are important factors when it comes to immunizations of mice or rats: MSP sourced from these species assure that the immune reaction is elicited by the membrane protein and not the nanodisc scaffold.
antibodies-online offers the following MSP Protein Variants
|MSP1D1||9.8nm (+/-1.1nm)||ABIN3199245 (Hs), ABIN3199248 (Mm), ABIN4886404 Rat (Rn)|
|MSP1D1-dH5||8.2nm (+/-0.6nm)||ABIN3199246 (Hs)|
|MSP1E3D1||12.1nm (+/-1nm)||ABIN3199247 (Hs), ABIN3199249 (Mm), ABIN4886405 Rat (Rn)|
|MSP2N2||16.0nm (+/-1nm)||ABIN3199238 (Hs)|
The phospholipid bilayer inside the nanodisc can be composed of different phospholipids or phospholipid mixtures to best suit the protein of interest. The lipid selection depends heavily on the protein and can have significant influence on its activity. Furthermore, proteins from different species require specific phospholipids: e.g. a human membrane protein typically requires a different phospholipid environment than a bacterial membrane protein. It is therefore advisable to screen various different phospholipids.
Commonly used phospholipids are palmitoyl-oleoyl-phosphatidylcholine (POPC), dimyristoyl-glycero-phosphocholine (DMPC), or dimyristoyl-phosphatidyl-glcyol (DMPG) 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC). There is however a plethora of phospholipids available to ideally accommodate the characteristics of your protein of interest.
Nanodiscs self-assemble from a mixture of the MSPs, phospholipids, and detergent upon removal of the detergent. The optimal ratio of the phospholipid to MSP is a critical parameter to assure complete self-assembly and homogenously sized nanodiscs. This ratio varies depending on the utilized MSP as well as the phospholipid. Furthermore, carefully controlling the molar ration between the target protein, the MSP, and lipids it is possible to assemble nanodiscs with different oligomeric state of the membrane protein (5).
Purified membrane proteins are spontaneously reconstituted upon addition of MSPs and phospholipids and removal of the detergent. In case of membrane bound proteins membrane phospholipids form also the bilayer in the nanodisc surrounding the protein after assembly. The presence of the native phospholipids can positively affect protein activity and structure. Furthermore, the exposure of the solubilized protein to detergent is significantly shorter.
In order to reconstitute membrane proteins in a nanodiscs, the protein can be expressed in a cell-free system in the presence of an assembled nanodiscs (Fig.2 A). Alternatively, the purified protein can be solubilized using an appropriate detergent (Fig.2 B). In a subsequent step, MSPs are and phospholipids are added to. Nanodiscs containing the membrane protein form spontaneously. A third option is to reconstitute the protein of interest in a nanodisc directly from membranes (Fig.2 C). Protein-nanodisc complexes can be purified from those in the original membrane by affinity chromatography via the His-tag on the MSP. The exposure time for (C) is considerably shorter than for (B).
|Agonist/antagonist binding and radiolabel exchange in G proteins||beta andrenergic receptor 2||human||(6)|
|Surface plasmon resonance (SPR)||CD4 mutant||human||(7)|
|Resonance Raman spectroscopy||cytochrome P450||mammalian||(8)|
|Time-resolved fluorescence spectroscopy||light harvesting complex II (LHCII)||spinach||(9)|
|Matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS)||various||various||(10,11)|
|Non-covalent mass spectrometry (LILBID-ESI-MS)||KcsA LspA, EmrE, Hv1, proteorhodopsin, MraY||human bacteria||(12)|
|Electron microscopy (EM)||light harvesting complex II (LHCII)||spinach||(13)|
|Cryo electron microscopy (EM)||cySecYEG complex, TcdA1 toxin complex||bacteria||(14, 15)|
|Mouse vaccination||hemagglutinin (HA)||influenza virus||(16)|
|Nuclear magnetic resonance (NMR)||OmpX CD4 mutant||human bacteria||(17, 18)|
|NMR analysis of lipid-interacting, soluble proteins||phospho-inositol binding proteins||human||(19)|
|Transfer into bicelles for NMR||lipoprotein signal peptidase II (LspA)||human||(20)|
|Protein phosphorylation / activation studies||epidermal growth factor receptor (EGFR)||human||(21)|